News Focus
News Focus
Followers 4
Posts 5195
Boards Moderated 1
Alias Born 03/21/2024

Re: jesster64 post# 776460

Thursday, 07/17/2025 11:33:21 AM

Thursday, July 17, 2025 11:33:21 AM

Post# of 823820
LOL, no regulatory agency will even consider this for anything outside GBM. Forget about approval. You have to run proper trials.

By the way, Specials revenue over the last few years will tell you everything you need to know about how much traction they have gotten, LOL! There is limited sample size of Specials data even for GBM. Forget about other indications! No doctors will stick their neck out to recommend a $200k therapy for other indications without proper clinical trial data and evidence. In fact, 99% of the oncology doctors outside GBM don’t even know NWBO and DCVAX!

They can’t even get approval for GBM indication 19 months post submission while the share price has been trading in .20s and minions pumping multiple indications outside GBM. LP just diluted at .22. Let that sink in!

As soon as the financiers dump their 17M+ shares to bag holders, we will be back to teens quickly. But hey it will be the market makers and manipulators then!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News